Abstract

Single-agent treatment of hypertension with either a j1-blocker or a calcium antagonist sometimes fails to adequately control blood pressure (Daniels & Opie 1986). Therefore, it may be reasonable to attempt combination therapy, for example, using atenolol plus nifedipine. This paper describes an on-going study of this j1-blocker and calcium antagonist combination designed to evaluate blood pressure control, incidence of unwanted effects, and biochemistry and haematology. The appropriate dose frequency and dosage of the 2 constituents of the combination was also evaluated.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call